VETINUITY
When were the affected products shipped?
The affected products were shipped between February 18, 2026 and October 6, 2026 to veterinary practices, pharmacies, and other customers nationwide in the U.S.
● ANSWER
Sourced & dated
Wedgewood Pharmacy compounded veterinary medication recall
Wedgewood Pharmacy is recalling certain compounded veterinary medications within expiry due to potential potency issues.
● WHAT'S DOCUMENTED
Wedgewood Pharmacy is recalling certain compounded veterinary medications within expiry due to potential potency issues.
The affected products were shipped between February 18, 2026 and October 6, 2026 to veterinary practices, pharmacies, and other customers nationwide in the U.S.
Veterinary practices should immediately examine their inventory, quarantine any affected product and contact Wedgewood’s recall services at 866-562-5931.
| FDA notice field | Value |
|---|---|
| Slug | wedgewood-pharmacy-recall |
| Firm | Wedgewood Pharmacy, LLC. |
| Title | Wedgewood Pharmacy Issues Recall of Certain Compounded Veterinary Medications Within Expiry Due to Potential Potency Issues |
| Company announcement date | October 21, 2026 |
| FDA publish date | October 21, 2026 |
| Product type | Animal & Veterinary Drugs |
| Reason | Potential Potency Issues |
| Product description | Compounded veterinary medications |
| Recall statement | is recalling certain compounded veterinary medications within expiry at the provider/customer level due to inconsistencies in the reliability of certain analytical testing data generated by their laboratory, potentially resulting in subpotent and/or superpotent products. |
| Products shipped | The affected products were shipped between February 18, 2026 and October 6, 2026 to veterinary practices, pharmacies, and other customers nationwide in the U.S. |
| Dosage forms | powders, pastes, oral suspensions, injectables, ophthalmic ointments and solutions, ear solutions and suspensions, topical sprays, and gels |
| Species | The products involved are intended for companion, equine, exotic, zoo, wildlife, and aquatic animals. They are not intended for use in food-producing animals. |
| Hazard | The health risks involved with low potency can include ineffective treatment and the health risks involved with high potency can include toxicity or overdose. |
| Complaints | To date, Wedgewood has received 98 complaints, of which 7 are serious. |
| For veterinary practices and pharmacies | Veterinary practices, pharmacies, and other customers should immediately examine their inventory, quarantine any affected product and contact Wedgewood’s recall services by phone at 866-562-5931 Monday through Friday 8am - 9pm ET and Saturday 9am to 5pm ET. |
| Further dispensed products | Veterinary practices or pharmacies who have further dispensed affected product should identify and notify their customers of the recall. |
| For animal owners | Animal owners who have received affected product should stop use, retain the product, and contact Wedgewood’s recall services by phone at 866-562-5931 Monday through Friday 8am - 9pm ET and Saturday 9am to 5pm ET. |
| Alternative treatment contact | To identify alternative treatment options, customers can contact Sedgwick by phone at 866-562-5931 Monday through Friday 8am - 9pm ET and Saturday 9am to 5pm ET. |
| FDA knowledge | This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. |
| Report adverse reactions or quality problems | Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA at 1888-FDA-VETS or online at http://www.FDA.gov/reportanimalae . |
| Wedgewood recall lookup | https://www.wedgewood.com/recall-lookup/ |
| Source | FDA company announcement, October 21, 2026 |
| FDA notice | https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/wedgewood-pharmacy-issues-recall-certain-compounded-veterinary-medications-within-expiry-due |
| Source fetched | 2026-11-11 |
Look up affected lot numbers on Wedgewood’s recall lookup page
● SOURCES
- 1. FDA company announcement, October 21, 2026. Company announcement. Checked 2026-11-11.
- 2. Wedgewood recall lookup. Recall lookup. Checked 2026-11-11.
● RELATED ANSWERS
- Veterinary drugs FDA drug shortage status and records
Track veterinary and human drug shortages using FDA Center for Veterinary Medicine tables and CDER records.
- Dextrose Drug Shortage Status and Supply
FDA lists human-labeled dextrose injection in shortage, with various concentrations showing available, limited, or unavailable supply.
- Dexmedetomidine Shortage Status and Veterinary Supply
FDA lists human-labeled dexmedetomidine injection in shortage, while Dexdomitor provides 0.1 mg/mL and 0.5 mg/mL veterinary formulations.
- Clindamycin FDA Drug Shortage Status for Veterinarians
FDA shortage status details for clindamycin injection, including manufacturer availability and supply dates.
- Lidocaine FDA Drug Shortage Status for Vets
FDA shortage status by lidocaine injection presentation, plus lidocaine and bupivacaine onset and duration for local blocks in dogs and cats.
● FAQ
How many complaints has Wedgewood received?
To date, Wedgewood has received 98 complaints, of which 7 are serious.
Which animals are the products intended for?
The products involved are intended for companion, equine, exotic, zoo, wildlife, and aquatic animals. They are not intended for use in food-producing animals.
● OPEN APP
SEE HOW VETINUITY HANDLES THIS.
Vetinuity explains clinical options with journal citations.
The veterinarian diagnoses and prescribes.